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Abstract 
Objectives 
We identified intermittent gait disturbance (IGD) observed in the mild stage of 
idiopathic normal pressure hydrocephalus (iNPH). The first purpose of this study was to 
clarify the temporal gait profile of IGD during long distance gait. The second purpose 
was to confirm the difference in treatment effect after cerebrospinal fluid (CSF) 
shunting in patients with and without IGD. 
Materials and Methods  
Fourteen consecutive iNPH patients with mild gait disturbance with a timed up-and-go 
(TUG) of less than 20 seconds were prospectively enrolled in the study. All patients 
were asked “Do you experience gait difficulty after over five minutes of walking?” 
Seven "yes" patients formed the IGD group, and seven "no" patients formed the 
persistent gait disturbance (PGD) group. One day before and seven days after CSF 
shunting, gait function was evaluated by the 6-minute walk test (6MWT) and TUG. 
Results 
Preoperatively, all patients in the IGD group demonstrated features of IGD during the 
6MWT, characterized by a progressive pattern of decreased gait speed and step length 
with increased cadence and absence of leg pain. Postoperatively, these features of IGD 
improved in all patients. In the PGD group, preoperative walking did not significantly 
worsen during the 6MWT and did not significantly change seven days after treatment. 
Improvement of gait symptoms one week after CSF shunting could be detected with 
6MWT instead of TUG. 
Conclusions 
IGD is not a rare symptom in mild stage of iNPH and may serve as an important clinical 
diagnostic marker for identifying mild iNPH patients.  
 
Key words: idiopathic normal pressure hydrocephalus, intermittent gait disturbance, 
intermittent claudication, CSF shunting, 6-minute walk test, gait disorder 
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Introduction 
Gait disturbances in idiopathic normal pressure hydrocephalus (iNPH) have been 
historically characterized by a persistent broad-based, short-stepped ‘magnetic’ gait.1–4 
However, the precise temporal nature of long distance gait has not been accurately 
described. We have recently identified an intermittent type of gait disturbance (IGD) in 
iNPH patients using the 6-minute walk test (6MWT).
5
 This pattern was particularly seen 
in mild and early stages of iNPH and seemed to be related to falls. Typically, patients 
complain about falling, but do not mention deterioration of gait after a walking load. 
Furthermore, IGD is difficult to identify in the examination room, because it is not 
apparent in short distance walking. Gait disorders in iNPH are usually considered to 
be a persistent, not transient deficit. Perhaps for this reason, evaluation of gait function 
included only used short-distance gait testing, such as the TUG,
2,6
 the 10 to 25 meters 
walk test,
7–9
 or other gait scoring systems that employ short distance gait measures.
10,11
  
 The 6MWT is widely used as gait loading test; reliability and validity of the 
6MWT have been established as a tool to evaluate walking endurance for the heart and 
lung diseases.
5
 However, 6MWT has not been applied to evaluate gait performance of 
iNPH patients. The purposes of this study were to clarify the temporal gait profile of 
IGD during long distance gait and to confirm the difference in treatment effect after 
cerebrospinal fluid (CSF) shunting in patients with and without IGD. A discussion of 
the pathophysiological mechanisms of IGD in iNPH and the implications of IGD as an 
early diagnostic marker of iNPH are presented. 
 
Materials and methods 
Patients 
Fourteen iNPH patients (11 men, 3 women, mean age 75.6 ± 4.1) with mild gait 
disturbance, which was defined as a timed 3-meter up-and-go test (TUG) of 20 seconds 
or less, were included in this study. Diagnostic criteria leading to CSF shunting are the 
national iNPH guidelines:
12
 (1) individuals with symptomatic onset at the age of 60 or 
older; (2) the existence of at least two items from the triad of gait disturbance, cognitive 
impairment, and urinary incontinence; (3) MRI-detected ventricular dilation (Evans 
Index > 0.3) accompanied by narrowing of the CSF space in the high convexity and 
interhemispheric ﬁssure; (4) CSF pressure of 200 mmH2O or less and normal CSF 
laboratory findings; (5) clinical symptoms not completely explained by other 
neurological or non-neurological conditions; (6) absence of other conditions associated 
with ventricular dilation, such as subarachnoid hemorrhage, head injury, meningitis, 
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congenital hydrocephalus, or aqueductal stenosis; and (7) a positive clinical response to 
a CSF tap test. Exclusion criteria included any neurological, orthopedic, or internal 
organ disorders influencing gait. Exclusion criteria also included neurogenic 
intermittent claudication (IC) and vascular IC, which may present IGD. 
A questionnaire was answered by all patients using the interrogative: “Do you 
experience gait difficulty after over five minutes of walking?” Based on this response, 
seven patients who answered "yes" formed the IGD group, and seven patients who 
answered "no" formed the persistent gait disturbance (PGD) group. 
Twelve patients underwent lumboperitoneal (LP) shunting, and two patients 
underwent ventriculoperitoneal (VP) shunting. A Codman-Hakim programmable valve 
was implanted in all cases, and its initial pressure settings were determined according to 
the patient’s height and weight with reference to Miyake’s quick reference table (QRT). 
13,14
 
Gait function was evaluated by registered physical therapists using the TUG
15
 and 
6MWT
5
 one day before (pre-OP) and one week after (post-OP) CSF shunt surgery. 
Cognitive function was evaluated pre-operatively by speech therapist using the 
Mini-Mental State Examination (MMSE)
16
 and Frontal Assessment Battery (FAB) .
17
 
 
Pre- and post-shunt gait assessment  
The TUG was consecutively performed three times over a period of 3 minutes 
and average times were calculated. The 6MWT was performed according to the 
standardized protocol of the American thoracic society.
5
 Prior to starting the 6MWT, 
patients were at rest in the sitting position for at least 10 minutes. The total gait distance 
and gait performances, including parameters of cadence, step length, and gait speed at 
60 second intervals, were measured during the 6MWT. Pulse rate was continuously 
monitored using a pulse oximeter throughout the 6MWT. Walking effort was evaluated 
based on the degree of increase in pulse rate. 
In order to eliminate the potential influence of footwear in the overall time of the 
TUG and 6MWT,
18
 all tests were performed using sneaker type footwear. For patients 
judged to be at risk of falling, an examiner followed all subjects at one-step behind each 
patient to prevent falling without interfering with their walking pace. 
 
Evaluation of iNPH symptom improvement 3 months after surgery 
Prior to surgery and 3 months after surgery, gait, cognitive, and urinary 
disturbance were evaluated by iNPH Grading Scale (iNPHGS)
10
 The treatment effect of 
CSF shunting was evaluated by iNPHGS. In the IGD group, the presence of IGD was 
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evaluated by physician interview at 3 months after surgery. 
 
Statistical analysis 
The Wilcoxon signed-rank test was conducted to measure differences between the 
pre-OP and post-OP results of the TUG and the total distance of the 6MWT. Analysis of 
step length, cadence, and pulse recordings during the 6MWT were conducted using 
two-way repeated measures ANOVA with two factors as time periods (1-min serration) 
between the pre-OP and post-OP periods for each group. The chronological changes of 
these gait factors in the 6MWT were also analyzed by two-way repeated measures 
ANOVA compared with the first one minute. The alpha level was set at 0.05. Data were 
presented as the mean ± standard deviation of the mean. 
 
Ethics statement 
The study protocol was approved by the ethics committee at the Osaka Medical 
College (No. 1555), and written informed consent was obtained from all patients or 
their caregivers. The study was carried out according to the Declaration of Helsinki. 
 
Results 
There were no significant differences in demographic data between the two 
groups (table 1, 2). 
 
Gait analysis of the IGD group by the 6MWT 
In the IGD group, pre-operatively all patients exhibited gradual aggravation of 
gait with increased walking time, and all gait parameters, including step length, cadence, 
and velocity, changed proportionally with gait loading (Fig. 1a-c). Step length and 
walking speed decreased significantly after three minutes, and cadence also increased 
significantly after three minutes compared with the initial 1-min recording. None of the 
patients complained of either hip or leg pain during the 6MWT. Propulsive gait was not 
observed in the beginning of the 6MWT before shunt surgery in all patients, however, 
propulsive gait was found in the latter half of the 6MWT before shunt surgery in four 
patients of IGD group. The gait disturbance that appeared in the second half of the 
6MWT recovered after a few minutes break. 
The pre-operative parameters of shortened step length, increased cadence, and 
reduced gait velocity after 3 minutes of gait loading observed in the IGD group 
significantly improved post-operatively (Fig. 1a-c). Consequently, the pre-operative 
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total walking distance of 236.5 ± 34.2 meters was significantly lengthened to 305.1 ± 
29.6 meters after CSF shunting (P = 0.018; Fig. 3a).   
 
Gait analysis of the PGD group by the 6MWT 
In the PGD group, pre-operatively all patients showed no significant aggravation 
of gait during gait loading (Fig. 2a-c). Furthermore, no significant improvements were 
observed in step length, cadence, and velocity after CSF shunting (Fig 2 a-c). However, 
total distance of the 6MWT in pre-operative test was slightly elongated compared with 
that in post-operative PGD test (PGD: pre-OP = 319.6 ± 20.6 meters vs post-OP = 327.4 
± 22.0 meters, P = 0.063; Fig. 3c).  
 
Gait analysis by the TUG 
There were no significant differences between the pre- and post-operative TUG 
results both in the IGD (pre-OP = 13.8 ± 2.3 seconds vs. post-OP = 13.3 ± 2.1 seconds, 
P = 0.151) and PGD group (pre-OP = 12.8 ± 2.0 seconds vs. post-OP = 12.3 ± 2.2 
seconds, P = 0.176; Fig.3b-d). 
 
Pulse rate changes during the 6MWT 
There were no significant changes in pulse rate observed during the pre- and 
post-operative 6MWT both in the IGD and PGD group (Fig 1d and Fig 2d). Therefore, 
pre- and post-operative walking effort was determined to be unchanged.   
 
Symptomatic recovery 3 months after CSF shunting 
In all cases, except for the IGD case 2, iNPHGS showed improvement of 1 or 
more (table 1, 2). After CSF shunting, the symptom of IGD rapidly disappeared in all 
cases, including case 2. 
 
Discussion 
Intermittent gait disturbance: A common but hidden symptom at the mild stage of iNPH 
This is the first report to describe a pattern of intermittent gait disturbance (IGD) 
in the mild stage of iNPH. Extended distance walking tests using the 6MWT showed 
that gait disturbance worsened proportionally with gait loading. The main characteristic 
of IGD is a progressive pattern of decreased gait speed and step length with increased 
cadence and absence of leg pain. Although the step width has not been evaluated in this 
study, the video movie shows that another characteristic of IGD is that it does not 
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involve wide base in IGD. The reason why the step width is not wide may be related to 
the fact that the gait disturbance is in the mild stage. The fact that no difference in pulse 
rate was observed before and after shunting suggested that fatigue may not be a 
causative factor in IGD associated with iNPH.  
 Gait difficulty is a well-known core symptom in iNPH patients and is typically 
characterized by signs of reduced gait velocity, diminished stride length, and reduced 
floor-to-floor clearance. Currently, all these signs have been shown to improve after 
treatment with CSF shunting.
2,4,19,20
 However, to date, the temporal nature of gait 
disturbance during long distance gait in iNPH has not been accurately described.  
 In contrast, we have shown that the TUG was not able to detect significant 
improvements in gait following CSF shunting in iNPH patients, especially with regards 
to the subtle features of IGD, while results using the 6MWT clearly demonstrated 
improvements after shunting. The reason that TUG is invalid in the detection of IGD is 
that although TUG is a complicated task including muscular strength and balance such 
as turning, standing and sitting, there is no aspect of walking load at all. Therefore, we 
postulate that the reason why IGD has not been previously recognized as a clinical 
feature of iNPH is that testing has focused on observation and evaluation of short 
distant gait only. In our study, 50% of the patients diagnosed with mild iNPH presenting 
with a TUG of less than 20 seconds showed signs of IGD.  Therefore, although the 
sample size was too small, our findings suggest the possibility that IGD may be a 
common finding in the early stage of iNPH. IGD may be a pre-clinical or hidden feature 
in iNPH, and this suggests the potential usefulness of IGD as a diagnostic tool for early 
diagnosis of iNPH. Further studies may more accurately identify the role of IGD in 
iNPH and may reveal a spectrum of gait disorders in iNPH, presumably with onset of 
initially intermittent gait dysfunction followed by progression to a complete persistent 
gait disturbance. 
In the PGD group, improvement in walking function could not be detected with 
TUG and 6MWT before and after surgery. However, the fact that iNPHGS improved in 
all cases of PGD group at 3 months after shunt surgery means that all patients in the 
PGD group are definite iNPH in Japan guide lines.
12
 This discrepancy is thought to arise 
from postoperative evaluation being performed only seven days after surgery. Seven 
days after surgery, it seems that the symptomatic improvement process is still in 
progress and the influence of surgical invasion and perioperative exercise restriction 
remains. On the contrary, despite such non-optimal conditions, improvement of IGD at 
6MWT indicates that IGD is a highly reversible symptom expected to be improved by 
shunt surgery. 
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Intermittent gait disturbance and intermittent claudication 
 Longer distance gait testing using the 6MWT revealed the subtle features of gait 
in IGD, which included decreases in gait speed and step length with increases in 
cadence proportional to gait distance. These features resemble well-known forms of 
intermittent claudication (IC), such as vascular IC (VIC) and neurogenic IC (NIC). VIC 
is typically caused by obstructive atherosclerosis and involves both decreases in step 
length and gait speed due to accompanying lower limb weakness or pain.
21,22
 In contrast, 
NIC is usually caused by spinal stenotic nerve root compression and is also associated 
with decreases in step length and gait speed with progressive radiating lower limb pain 
after sustained gait.
23,24
  
 However, there are potentially three major differences between the features of 
IGD and the classical types of IC. First, in contrast to VIC and NIC, IGD in iNPH does 
not seem to be associated with either lower limb pain or weakness induced by 
ambulatory loading. Second, cadence was shown to gradually increase in IGD, while 
cadence is reported to decrease in VIC and NIC because of leg pain or weakness.
21,23
 
We believe the increasing cadence observed in IGD is a compensatory mechanism for 
decreases in gait speed and shortening of step length. Third, IGD in iNPH is frequently 
associated with balance disturbances, such as propulsive gait, which increases the 
inherent risks of falling. These potential differences between IGD and IC are 
summarized in table 3. However, as there is a fundamental common point that it 
develops gait disturbance accompanying walking load and is reversible, IGD may be 
termed hydrocephalic IC as a new category of IC. 
 
Ischemic mechanism in early stage of iNPH 
Gait difficulty in VIC and NIC is thought to be related to progressive ischemia of 
muscles and nerves with walking load.
25,26
 Because both IGD and other types of IC 
have a progressive onset, it is possible that ischemia is also involved in the pathogenic 
mechanism of IGD. Although the exact ischemic pathophysiological mechanisms 
underlying gait disturbances in iNPH are still controversial, a model of vascular 
compression and successive decrease in cerebral blood flow (CBF) has been proposed 
by Batman et al.
27
 Another research has been directed at investigating the nature of 
decreased CBF in the frontal lobe and periventricular white matter.
8,28,29
 Our results tend 
to support an ischemic mechanism for the onset of symptoms in iNPH patients in the 
early stage because of the short temporal relationship of symptoms with progressive gait 
loading.  
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Intermittent gait disturbance as a mild and early sign of iNPH 
Preoperative gait and cognitive function tests indicate that the IGD group is in 
the mild stage. Regarding gait function, a preoperative TUG of 13.8 seconds (10.9-16.6) 
in the IGU group can be regarded as a mild stage. The normal range of TUG is still 
controversial. For individuals without disability between 70 and 89 years of age, the 
TUG has been reported to range from 7 to 12 seconds.
30
 In the geriatric population, 
TUG scores greater than 13.5 seconds have been associated with an increased risk of 
falls.
31
 As for cognitive function, the pre-operative mean MMSE of 27 was within the 
normal range as adjusted for age.
32,33
 The pre-operative mean MMSE in prior studies on 
the surgical treatment of iNPH, such as the SINPHONI, SINPHONI-2, and Kuopio 
NPH study, were 25, 23, and 20, respectively.
2,34,35
 Furthermore, since iNPH is a 
progressive disease, the mild stage can be interpreted as being an early stage. 
 
Keys for recognizing intermittent gait disturbance 
An important key for recognizing IGD is appropriate early patient questioning 
especially in the outpatient setting, when the subtle early signs of gait disturbance 
induced by gait loading first appear. These early signs may go unnoticed by the patient 
or primary care physician or may be masked by presentation as falls, and can only be 
uncovered and clarified by detailed direct questioning such as: “Do you experience gait 
difficulty after over five minutes of walking?”. In addition, when considering the 
indications for shunting in iNPH patients with mild symptoms, we have recommended 
long distance gait testing as an adjunct to standard guideline testing of gait function.  
 
Conclusions 
 IGD is a novel and previously unnoticed feature of mild iNPH. IGD is 
characterized by a decrease in step length and gait speed and by an increase in cadence 
without leg pain after gait load. Long distance walking tests, such as 6MWT and asking 
questions focusing on IGD in falling elderly patients may lead to identification of IGD. 
Further studies on IGD may lead to earlier diagnosis of iNPH with possible improved 
surgical outcomes. 
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Averaged step length (a), cadence (b), and velocity (c) per minute for the 6MWT in the 
IGD group. Pre-operative gait parameters with gait loading significantly improved 
post-operatively. Asterisks indicate significant changes as compared with pre-operative 
6MWT (p < 0.05). There were no significant differences in pulse rate between the 
pre-operative and post-operative 6MWT (d). 
 
 
 
 
 
 
 
 
Averaged step length (a), cadence (b), and velocity (c) per minute for the 6MWT in the 
PGD group. Pre-operative gait parameters with gait loading did not improve 
post-operatively. There were no significant differences in pulse rate between the 
pre-operative and post-operative 6MWT (d). 
Figure 1 
Figure 2 
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The total walking distance (a) for the 6MWT in the IGD group was significantly 
lengthened post-operatively (p = 0.018). Asterisks indicate significant changes as 
compared with pre-operative 6MWT (p < 0.05). There was no significant difference 
between the pre-operative and post-operative TUG in the IGD group (b). In the PGD 
group, no significand difference between the pre-operation and post-operation was 
observed not only at TUG (d) but also at 6MWT (c). 6MWT, 6 Minute Walk Test; TUG, 
timed 3-m up-and-go test; CSF, cerebrospinal fluid 
 
 
  
Figure 3 
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